Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Embedded Multifactorial Adaptive Platform in ExtraCorporeal Membrane Oxygenation - Beta Receptor Modulation Trial

NCT06522594 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06522594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06522594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Embedded Multifactorial Adaptive Platform in ExtraCorporeal Membrane Oxygenation - Beta Receptor Modulation Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2024
Completion date
December 3, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, heart failure